Skip to content

Medical Affairs

Intelligence Hub

Overview

Home
My Work
Command Center

Plan & execute

Medical Plans
Launch Readiness
Budget & Resources
Risks & Decisions

Field & science

Engagements
Insights
Evidence Generation

Communicate

Publications
Congresses
Medical Information

Govern

Reports
Data Quality
Administration

Helixor Therapeutics

Sample data · FY2026

Scope·4 products·FY2026

HODr. Helen OkaforGlobal Head of Medical Affairs

EngagementsENG-0021

Scientific exchange · Dr. Liam Quinn

18 Jun 2026 · In person · Dr. Liam Quinn, Royal Marsden · MSL Rachel Adeyemi · Vantrexa

ReviewedVeeva CRMENG-0021—

Capture insight from this engagement

Location: Royal Marsden
Therapeutic area: Oncology
Country: United Kingdom
Stakeholder tier: Tier 1
Strategic objective: SO-VTX-02 · Close the post-progression sequencing evidence gap through a real-world cohort a…
Initiative: Tier 1 thoracic oncology KOL engagement programme
MSL: RARachel AdeyemiMSL, Oncology (UK & Ireland)
Product: Vantrexa (vantrelimab)

Topics discussed

Sequencing after progression

Scientific content used

VTX core scientific deck v3.2
VOYAGE-1 pivotal data summary

Questions raised

What is the evidence for re-challenge with checkpoint inhibitors after progression on vantrelimab?

Notes

Consultant asked for recommended approach after progression; UK NSCLC network drafting pathway document.

Insights captured (1)

Capture insight

INS-0031Critical
Sequencing after progression
UK network drafting post-progression pathway; will default to docetaxel absent sequencing evidence. Time-sensitive opportunity to inform pathway with available data.
Action in progress

Review workflow

Draft
Submitted
3Reviewed

Review complete. Quality ratings and insights can now be used in aggregates.

Follow-ups

Share MI standard response
Schedule follow-up in 6 weeks

0 of 2 complete

Quality ratings

1–5, rated at review

Scientific relevance: 5
Strategic relevance: 2
Depth of exchange: 1
Actionability: 2

Data lineage

Source system: Veeva CRM
Sync: Veeva CRM · synced 2026-09-15 08:00 UTC
System of record: Veeva CRM
Record id: ENG-0021

Audit history (0)

All create, update and approval events for this record

No audit events in sample data